Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Aaltonen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1980
[Phenylephrine as a mydriatic]L Salminen, H Aaltonen
Ophthalmic Research|January 1, 1984
Visual thresholds in the deutan type of red-green deficient colour visionH Aaltonen, E Aarnisalo, V Elenius
BMJ (Clinical Research Ed.)|December 4, 1998
Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortalityH Aaltonen, O Kilkku, E Heinonen, et al.
Biochemistry International|December 1, 1985
Studies on the degradation of ornithine decarboxylase by the immunoblotting techniqueA Pulkka, T Taskinen, H Aaltonen, et al.
Neurorehabilitation and Neural Repair|April 12, 2002
Selegiline treatment facilitates recovery after strokeJ Sivenius, T Sarasoja, H Aaltonen, et al.
Molecular and Clinical Oncology|May 23, 2017
Comparison of lifestyle, hormonal and medical factors in women with sporadic and Lynch syndrome-associated endometrial cancer: A retrospective case-case studyMari H Aaltonen, Synnöve Staff, Jukka-Pekka Mecklin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1980
[Phenylephrine as a mydriatic]L Salminen, H Aaltonen
Ophthalmic Research|January 1, 1984
Visual thresholds in the deutan type of red-green deficient colour visionH Aaltonen, E Aarnisalo, V Elenius
BMJ (Clinical Research Ed.)|December 4, 1998
Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortalityH Aaltonen, O Kilkku, E Heinonen, et al.
Biochemistry International|December 1, 1985
Studies on the degradation of ornithine decarboxylase by the immunoblotting techniqueA Pulkka, T Taskinen, H Aaltonen, et al.
Neurorehabilitation and Neural Repair|April 12, 2002
Selegiline treatment facilitates recovery after strokeJ Sivenius, T Sarasoja, H Aaltonen, et al.
Molecular and Clinical Oncology|May 23, 2017
Comparison of lifestyle, hormonal and medical factors in women with sporadic and Lynch syndrome-associated endometrial cancer: A retrospective case-case studyMari H Aaltonen, Synnöve Staff, Jukka-Pekka Mecklin, et al.
Pageof 1